2017 American Transplant Congress
Opioid and Opioid Substitution Therapy in Liver Transplant Candidates: A Survey of Center Policies and Practices.
Background: Chronic opioid use for pain and opioid substitution therapy (OST) are common among patients with cirrhosis. Little is known of transplant center policies and…2017 American Transplant Congress
Photopheresis for Recalcitrant Rejection After Heart Transplantation: Worthwhile?
Cedars-Sinai Heart Institute, Los Angeles
Background: Rejection is leading cause of mortality after heart transplantation (HTx). While the rates of rejection have declined over the past few decades from improvement…2017 American Transplant Congress
Time to First Therapeutic Tacrolimus Level: What Impact Does It Have After Heart Transplantation?
University of Pittsburgh Medical Center, Pittsburgh, PA
Purpose: Appropriate time to therapeutic immunosuppression levels is not well defined. The purpose of this study is to investigate outcomes related to time to therapeutic…2017 American Transplant Congress
Platelets Stimulate Liver Sinusoidal Endothelial Cells to Secrete Interleukin-6 During the Early Phase of Liver Regeneration in Mice.
Background and aimsPlatelets and liver sinusoidal endothelial cells (LSEC) are known to both independently regulate liver regeneration. Our aim was to investigate the role of…2017 American Transplant Congress
Primary Urtero- Ureterostomy in Renal Transplant, an Old Forgotten but Promising Technique.
John C McDonald Regional Transplant Center, Shreveport
Introduction:Ureter anastomosis is considered the achilles heel of renal transplant. Different types of Uretero-neocystostomy anastomosis techniques have been used as well as Uretero-Ureterostomy but latter…2017 American Transplant Congress
Outcomes After Cholecystectomy in Patients with End Stage Renal Disease.
INTRODUCTION: Patients awaiting kidney transplantation are at an increased risk of cholelithiasis and cholecystitis secondary to physiologic changes related to renal failure. Previous studies of…
